These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24850740)

  • 41. E6 proteins from high-risk HPV, low-risk HPV, and animal papillomaviruses activate the Wnt/β-catenin pathway through E6AP-dependent degradation of NHERF1.
    Drews CM; Case S; Vande Pol SB
    PLoS Pathog; 2019 Apr; 15(4):e1007575. PubMed ID: 31002735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interactions between E6AP and E6 proteins from alpha and beta HPV types.
    Thomas M; Tomaić V; Pim D; Myers MP; Tommasino M; Banks L
    Virology; 2013 Jan; 435(2):357-62. PubMed ID: 23206439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sodium arsenite suppresses human papillomavirus-16 E6 gene and enhances apoptosis in E6-transfected human lymphoblastoid cells.
    Chou RH; Huang H
    J Cell Biochem; 2002; 84(3):615-24. PubMed ID: 11813266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain.
    Mansur CP; Marcus B; Dalal S; Androphy EJ
    Oncogene; 1995 Feb; 10(3):457-65. PubMed ID: 7845670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship between HPV16/18 E6 and 53, 21WAF1, MDM2, Ki67 and cyclin D1 expression in esophageal squamous cell carcinoma: comparative study by using tissue microarray technology.
    Qi ZL; Huo X; Xu XJ; Zhang B; Du MG; Yang HW; Zheng LK; Li J; Shen ZY
    Exp Oncol; 2006 Sep; 28(3):235-40. PubMed ID: 17080019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of p53 and the PDZ domain containing protein MAGI-3 regulation by the E6 protein from high-risk human papillomaviruses.
    Ainsworth J; Thomas M; Banks L; Coutlee F; Matlashewski G
    Virol J; 2008 Jun; 5():67. PubMed ID: 18518978
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation.
    Conrady MC; Suarez I; Gogl G; Frecot DI; Bonhoure A; Kostmann C; Cousido-Siah A; Mitschler A; Lim J; Masson M; Iftner T; Stubenrauch F; Travé G; Simon C
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of C/EBPα as a novel target of the HPV8 E6 protein regulating miR-203 in human keratinocytes.
    Marthaler AM; Podgorska M; Feld P; Fingerle A; Knerr-Rupp K; Grässer F; Smola H; Roemer K; Ebert E; Kim YJ; Bohle RM; Müller CSL; Reichrath J; Vogt T; Malejczyk M; Majewski S; Smola S
    PLoS Pathog; 2017 Jun; 13(6):e1006406. PubMed ID: 28640877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncoprotein expression of E6 and E7 does not prevent 5-fluorouracil (5FU) mediated G1/S arrest and apoptosis in 5FU resistant carcinoma cell lines.
    Didelot C; Mirjolet JF; Barberi-Heyob M; Ramacci C; Teiten MH; Merlin JL
    Int J Oncol; 2003 Jul; 23(1):81-7. PubMed ID: 12792779
    [TBL] [Abstract][Full Text] [Related]  

  • 50. p53, WAF1/CIP1 and mdm2 expression in skin lesions associated with human papillomavirus and human immunodeficiency virus.
    Arany I; Yen A; Tyring SK
    Anticancer Res; 1997; 17(2B):1281-5. PubMed ID: 9137486
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ubiquitination and proteasome degradation of the E6 proteins of human papillomavirus types 11 and 18.
    Stewart D; Kazemi S; Li S; Massimi P; Banks L; Koromilas AE; Matlashewski G
    J Gen Virol; 2004 Jun; 85(Pt 6):1419-1426. PubMed ID: 15166424
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activating transcription factor 3 activates p53 by preventing E6-associated protein from binding to E6.
    Wang H; Mo P; Ren S; Yan C
    J Biol Chem; 2010 Apr; 285(17):13201-10. PubMed ID: 20167600
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cross-talk of cutaneous beta human papillomaviruses and the immune system: determinants of disease penetrance.
    Venuti A; Lohse S; Tommasino M; Smola S
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1773):20180287. PubMed ID: 30955489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein.
    Mietz JA; Unger T; Huibregtse JM; Howley PM
    EMBO J; 1992 Dec; 11(13):5013-20. PubMed ID: 1464323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myc and human papillomavirus type 16 E7 genes cooperate to immortalize human keratinocytes.
    Liu X; Disbrow GL; Yuan H; Tomaic V; Schlegel R
    J Virol; 2007 Nov; 81(22):12689-95. PubMed ID: 17804506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.
    Kessis TD; Slebos RJ; Nelson WG; Kastan MB; Plunkett BS; Han SM; Lorincz AT; Hedrick L; Cho KR
    Proc Natl Acad Sci U S A; 1993 May; 90(9):3988-92. PubMed ID: 8387205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. E6 and E7 proteins from different beta-papillomaviruses types do not interfere in UVB-induced apoptosis of HaCaT keratinocytes.
    Guerrini JS; Bouvard V; Oswald E; Alonso A; Prétet JL; Tommasino M; Mougin C; Aubin F
    Exp Dermatol; 2011 Jan; 20(1):71-3. PubMed ID: 21158941
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins.
    Harden ME; Prasad N; Griffiths A; Munger K
    mBio; 2017 Jan; 8(1):. PubMed ID: 28049151
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Co-expression of low-risk HPV E6/E7 and EBV LMP-1 leads to precancerous lesions by DNA damage.
    Uehara K; Tanabe Y; Hirota S; Higa S; Toyoda Z; Kurima K; Kina S; Nakasone T; Arasaki A; Kinjo T
    BMC Cancer; 2021 Jun; 21(1):688. PubMed ID: 34112111
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transactivation activity of human papillomavirus type 16 E6*I on aldo-keto reductase genes enhances chemoresistance in cervical cancer cells.
    Wanichwatanadecha P; Sirisrimangkorn S; Kaewprag J; Ponglikitmongkol M
    J Gen Virol; 2012 May; 93(Pt 5):1081-1092. PubMed ID: 22278827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.